Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $370.2100 (0.89%) ($367.3500 - $374.8100) on Tue. Jan. 16, 2018. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.48% (three month average) | | RSI | 44 | | Latest Price | $370.2100(0.89%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | | Weekly Trend | REGN declines -2% a week on average for past two weeks. | | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | | Factors Impacting REGN price | REGN will decline at least -0.74% in a week (0% probabilities).
UUP(-10%) VIXM(-7%) TLT(-6%) TIP(-1%) SHY(-1%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.74% (StdDev 1.48%) | | Hourly BBV | 0 () | | Intraday Trend | 0.3% | | | | | |
|
| Resistance Level | $379.32 | | 5 Day Moving Average | $368.11(0.57%) | | 10 Day Moving Average | $375.27(-1.35%) | | 20 Day Moving Average | $379.32(-2.4%) | | To recent high | -16.9% | | To recent low | 3.2% | | Market Cap | $39.253b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |